| Education |
Medical School: Charles university, 1st Faculty of Medicine, Prague
Residency: Allegheny General Hospital, MCP * Hahnemann University, Pittsburgh, PA
Fellowships: Allegheny General Hospital, MCP * Hahnemann University, Pittsburgh, PA
Cleveland Clinic Foundation, Cleveland, OH
Harvard School of Public Health, Boston, MA (MPH)
|
| Recent Publications: |
Stehlik J, Starling RC, Movsesian MA, Fang JC, Brown RN, Lewis NP, Hess ML, Kirklin JK. Utility of Long-Term Surveillance Endomyocardiall Biopsy. A Multiinstitutional Aalysis. J Heart Lung Transplant. 2006 Dec;25(12):1402-9.
Kfoury AG, Stehlik J, Renlund, DG; Snow G, Seaman JT, Gilbert EM, Stringham JS, Long JW, Hammond ME: The Impact Of Repetitive Episodes Of Antibody-Mediated Or Cellular Rejection On Cardiovascular Mortality In Cardiac Transplant Recipients: Defining Rejection Patterns; J Heart Lung Transplant; 2006 Nov;25(11):1277-82. Epub 2006 Oct 16.
Hammond ME, Stehlik J, Snow G, Renlund DG, Seaman J, Dabbas B, Gilbert EM, Stringham JC, Long JW, Kfoury AG. Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies.. J Heart Lung Transplant. 2005 Dec;24(12):2015-21.
Stehlik J, Movsesian MA. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure. Expert Opin Investig Drugs. 2006 Jul;15(7):733-42.
Stehlik J, Taylor DO. And an ARB makes nine: Polypharmacy in patients with heart failure. Cleve Clin J Med. 2004; Aug 71(8): 674-7
Stehlik J, Maholic RL, Thaman R. Images in cardiovascular medicine. Massive left ventricular aneurysm. Circulation. 2004 May 4;109(17): e203-4.
|